Stay updated with breaking news from Admission Document. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Assessment showed participants who received a single dose of SLN360 maintained median reductions over 80% over a five-month period Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company")
– Assessment showed participants who received a single dose of SLN360 maintained median reductions over 80% over a five-month periodLONDON--(BUSINESS WIRE)--$SLN #SenseofSilence--Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), an experienced and innovative biotechnology company committed to trans...
Investegate announcements from Aurrigo Int PLC, Agreement with Changi Airport Group
Investegate announcements from BWP REIT PLC, Schedule Two Update
The Luxembourg Stock Exchange (the "LuxSE") decided to exempt the admission of certain types of securities to trading on the EuroMTF market from the…